Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 17, 2018

DrugPatentWatch Database Preview

Actavis Labs Fl Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?

ACTAVIS LABS FL has seventy-seven approved drugs.

There are two tentative approvals on ACTAVIS LABS FL drugs.

Summary for Actavis Labs Fl

US Patents:	0
Tradenames:	61
Ingredients:	59
NDAs:	77

Drugs and US Patents for Actavis Labs Fl

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Labs Fl Inc	CABERGOLINE	cabergoline	TABLET;ORAL	078035-001	Apr 21, 2008	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Labs Fl Inc	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076049-002	Jan 14, 2005		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Labs Fl Inc	GLIMEPIRIDE	glimepiride	TABLET;ORAL	076995-003	Apr 27, 2010		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Labs Fl	GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE	guaifenesin; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	091071-002	May 27, 2015		OTC	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Labs Fl Inc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	206470-001	Jun 2, 2016	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Labs Fl Inc	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	076608-002	Dec 3, 2004		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter

McKinsey

Express Scripts

Teva

Julphar

US Department of Justice

Queensland Health

US Army

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.